individual and with the site of fluid removal. The accepted reference interval for fluid from the lumbar region in patients between the ages of 10 and 40 years is 150-450 mgfL, while infants and individuals older than 40 show higher concentrations. Fluids from the ventricular and cisternal regions generally have a lower protein content than that drawn from the lumbar region.
An overview of CSF protein composition can be obtained by performing agarose gel electrophoresis on a sample which has been concentrated 80-to 100-fold ( Figure 1 , sample N). The pattern from a normal adult shows a prominent prealburnin fraction that migrates slightly faster than plasma prealbuinin. Albumin is the major band on electrophoresis, comprising from 55 to 75% of the normal CSF protein. The aj-band consists primarily of aj-antitrypsin, the a-lipoprotein fraction being greatly decreased. The a2-region is not a dominant fraction, as with plasma, owing to relative decreases in large proteins such as a2-macroglobulin and the polymeric haptoglobin phenotypes.
Transferrin is detected
in the nj-region, and the major 2 protein is a carbohydrate-deficient "CSF-specific" transferrin.
The 'y-region, consisting almost exclusively of immunoglobulin G (IgG), can show some very faint banding in normal samples. The cathodal end of this zone often contains a low-Mr, nonimmunoglobulin protein, 7-trace, which is perhaps synthesized within the central nervous system, but has undetermined clinical significance
(4).
Most investigations of CSF proteins in neurological disease have concentrated on assessment of blood-CSF barrier permeability and abnormal protein production within the central nervous system (5). Many disorders with widely varying etiologies result in increases in permeability, and data on the status of the blood-CSF barrier is usually pathophysiologic, rather than diagnostic (6) . Detection of increased IgG synthesis in the central nervous system and the associated ohgoclonal banding phenomenon, however, is valuable in the diagnosis of demyehinating disease . In addition, measurements of some proteins present in low concentrations in the cerebrospinal fluid show promise in monitoring the demyehinating process and in diagnosing central nervous system involvement in patients with leukemia and lymphoma (11, 12) .
Assessing Permeability of the Blood-CSF Barrier
Many disorders of the central nervous system can increase the permeability of the blood-CSF barrier, leading to increased concentrations of CSF proteins. These disorders include bacterial, viral, and other forms of meningitis; neoplastic infiltration of the meninges; spinal and cerebral tumors; polyneuropathies; disk herniations; and cerebral infarctions (13) (14) (15) (16) (17) (18) . Even though demonstration of increased barrier permeability is usually not helpful in differentiating among these conditions, it can have diagnostic value when considered along with other laboratory data. It can also be useful in monitoring a patient's clinical condition. The convalescent stage of bacterial meningitis, for example, is usually accompanied by a progressive decrease in permeability of the blood-CSF barrier toward normal.
The integrity of the blood-CSF barrier is most commonly assessed through measurement of CSF total protein, but recent studies show that quantitation of a high-Mr protein can be a more sensitive indicator of mild barrier disturbances (19) . One drawback of this approach, however, is that large proteins-e.g., (2-macroglobuhin-are present in the CSF at very low concentrations and are therefore difficult to measure. Most quantitative immunochemical methods for specific proteins are also not easily adapted for emergency procedures. Until these methodological difficulties for specific proteins are overcome, CSF total protein will remain a valuable laboratory tool in some neurological diseases, particularly those of an inflammatory nature. Protein ratios can also be used to estimate bhood-CSF barrier permeability.
Several groups have examined the CSF/serum ratios of albumin and IgG and compared them graphically (20) (21) (22) (23) (24) . This multivariate approach results in a two-dimensional reference area for normal individuals and produces a straight-line indicator of permeability increases. Albumin, not being synthesized to any extent within the central nervous system, serves as the reference protein for monitoring permeability.
Thus, any increase in the CSF/ serum albumin ratio indicates increased passage of that protein across the barrier. The second protein, lgG, is measured both because of its larger molecular size and the fact that its increased production within the central nervous system has important clinical implications. Calculations for the regression lines of ratio plots where y = CSF/serum IgG and x = CSF/ serum albumin have been published by two groups of investigators. Britain et al. (21) reported y = 0.588x -4.0 X 10 with a standard error of estimate of 7.0 X 10, and Reiber (24) pubhishedy = 0.41x + 1.4 X i0 withastandard error of estimate of 5.0 X 10. Data from other groups show similarities when presented in graphic form, but regression equations were not calculated (20, 22) .
The most extensive studies on the nature of protein filtration and secretion at human body fluid barriers have been carried out by Felgenhauer et al. (3, 6, [25] [26] [27] .
They assessed permeability of the blood-CSF barrier by measuring several specific proteins in blood and CSF, and determined how the concentration ratios varied with the physical properties of the molecules. They found that hydrodynamic radius, i.e., the radius of the free diffusional volume, was the most important parameter in determining passage through the blood-CSF barrier. They further showed that for some high-Mr proteins, the hydrodynamic radius did not directly correspond with molecular mass. They concluded that the barrier could be characterized by plotting the serum/CSF protein ratios on a log scale vs hydrodynamic volume. When this was done, the position of the "permeability line" on the ordinate provided information on the amount of protein passing through the barrier, and the slope of the line correlated with barrier selectivity. The normal blood-CSF barrier was found to have low selectivity when compared with the normal renal gbmerulus and other body fluid barriers. They also showed that pathological conditions involving increased permeability were usually not accompanied by substantial changes in the selectivity of the blood-CSF interface (6, 27) .
These newer approaches of measuring protein ratios and plotting the results have as their common aim a more quantitative and sensitive assessment of the permeability of the blood-CSF barrier. This is expected to be useful in detecting more subtle changes in disease than is currently possible. Even though these methods show promise, their clinical implications have not yet found acceptance for routine use except in ruling out increased permeability as the cause for an increased concentration of IgG in CSF. This aspect will be discussed in the next section.
Abnormal Productionof Protein within the Central Nervous System
Demyelinating diseases. In 1948 Kabat et al. (28) measured proteins in CSF by the quantitative precipitin method and reported that eight of 14 patients with multiple sclerosis exhibited increased y-globulin. This finding was not thought to be diagnostic of multiple sclerosis, because the study also showed 15 of 16 cases of neurosyphihis to have the same abnormality. These workers had, however, demonstrated increased immunologic activity in the central nervous system in demyelinating disease. Since then, numerous investigators have searched for the cause of this immunologic activity and for more sensitive and specific diagnostic tests for demyelinating diseases.
Quantitative immunochemical studies have shown that the increased 7-globulin content of CSF in multiple sclerosis is from synthesis of IgG within the central nervous system (13-15, 17, 29-34) . The specific antigenic stimulant for this abnormal production of IgG has not been discovered, but mechanisms suggesting slow virus infection and autoimmune reaction have been proposed (35) (13) (14) (15) 17) .
Evaluation of CSF concentrations of IgG must take into consideration the condition of the bbood-CSF barrier, to distinguish increases resulting from leakage of plasma proteins across the barrier from increased synthesis in the central nervous system. The first useful method of taking perme- ability into account was to express CSF IgG as a percentage of CSF total protein (7, (13) (14) (15) 17, 30, 31, 33, 34) .
In one study, 88% of patients with multiple sclerosis gave "positive" results (17) , while other investigators (7, 13, 15) Ganrot and Laurell (20) showed that the diagnostic value of CSF protein measurements could be further enhanced if serum concentrations of protein were also taken into account.
By measuring
IgG and albumin in both fluids, any CSF abnormalities resulting from increases or decreases in the serum proteins could be accounted for. A graphic presentation of these protein ratios allows for discrimination between patients without protein abnormalities and those with barrier disturbances (as discussed in the previous section), those with increased central nervous system production of IgG, and those with combined disorders.
Other groups have used this dualratio approach, and some have published reference values for the coefficient of the two ratios in healthy adults (7, 21-24, 37, 38) . The mean values and ranges for this coefficient are given in Table 1 . The mean values for the coefficient show remarkable similarity, considering the facts that different analytical methods were used and reference populations from three separate countries were studied. In the most extensive study, Link and Tibbhing (7, 22, 23) found that 86% of patients with multiple sclerosis gave values above their reference range for the ratio coefficient. Britain et al. (21) reported that eight of nine multiple sclerosis patients had increased ratio coefficients.
Tourtelbotte
(39) has proposed further manipulation of serum and CSF IgG and albumin data in a formula to estimate the rate of IgG synthesis within the central nervous system.
His approach
uses albumin as a quantitative marker for blood-CSF barrier permeability, and corrects for both IgG leakage into the central nervous system and serum concentrations of IgG by incorporating a series of constants into the equation. The constants take into account such factors as the average normal rate of CSF formation, the average normal concentrations of IgG and albumin in serum and CSF, and the molecular mass ratio of albumin to IgG. The equation, in effect, factors out all sources of CSF IgG except de novo synthesis, and expresses the results as milligrams of IgG synthesized per day. Perhaps the major advantage of this approach is that results expressed this way are more easily understood than the dimensionless ratio coefficients published by others (21, 22, 37, 38) . However, the analytical measurements are the same in both cases, and the synthetic rate ex- (11, 49, 50) . Given that myehin fragments were known to be present in the CSF of most patients with active multiple sclerosis, an assay was developed to measure one of its components, myelin basic protein.
Cohen et al. (11) showed that patients with active demyehinating processes had high concentrations of this protein 
Fig. 2. Mechanismsof proteinuria
In normal function, glomerular filtration greatly decreases the concentrations of most large proteins (Mr >40 000; left-hand set of arrows in sketch), which are present In high concentrations of plasma, while aliowhtg almost free passage of low-M, proteins (Mr <15 000; ri'it-hand arrows), present in low concentrations in plasma. The tubules reabsorb almost all (95-99%) of the normally filtered proteins, so that very few remain in normal urine-mainly albumin, low-Mr proteins, and immunoglobulin components In glomerular proteinuria, increased glomeruiar permeability leads to higher concentrations of large proteIns in the glomerular filtrate. Some of these are reabsorbed by the tubules, along with low-Mr proteins. Ultimately, however, the urine contains increased amounts of proteins, which are usually retained at the glomerulus in tubular proteinuria, diminished tubular reabsorptive capacity results in a marked increase in urinary excretion of low-Mr proteins 
Urinary Proteins of Plasma Origin
Filtration of plasma across the glomerular capillary membrane, the initial event in the formation of urine, produces fluid containing a greatly decreased content of proteins with molecular masses >40 000 daltons. Very small plasma proteins are normally filtered almost freely through the glomeruhi and are subsequently reabsorbed by the renal tubules. Normal urinary protein excretion, therefore, is less than 150 mg/day (53) (54) (55) (56) (57) (58) (59) . Two-thirds of this is made up of filtered plasma proteins-primarily albumin, low-Mr species, and immunoglobulin components.
The remainder is derived from the urinary tract itself (60) . Immunochemical methods have allowed detection of numerous plasma proteins in normal urine (61) (62) (63) (64) (65) (66) (67) (68) . The extensive investigations of Hemmingsen and Skaarup (67) showed a wide and uneven distribution of urine protein excretion in healthy individuals, characterized by many points clustered at low quantities, with much "tailing" of data toward higher values. They also found large physiologic day-to-day variations for excretion of several proteins in a healthy subject. This finding is in striking contrast to the small physiologic variations reported for proteins in plasma (69) (70) (71) . The lack of adequate reference intervals for specific urine protein components has limited most investigators to studies of clear-cut proteinuria, or cases in which concentrations of individual proteins may be increased. This approach helps avoid distinctions between patients with normal renal function and those with only slight abnormalities. Figure 2 gives a description of how proteins are normally handled by the kidney and illustrates two common mechanisms of proteinuria involving proteins of plasma origin. Proteinuria in renal disease can be classified as resulting from either glomerular or tubular dysfunction. Glomerular proteinuria results from increased transcapillary passage of proteins through the glomerulus and is characterized by the loss of plasma proteins the size of albumin or larger (54, (56) (57) (58) (72) (73) (74) (75) (76) (77) (78) (79) (80) . Tubular proteinuria is caused by a decreased capacity of the tubules to reabsorb proteins.
With normal glomerular function, the glomerular filtrate contains high concentrations of lOWMr proteins to be reabsorbed by the tubules. Thus, impaired tubular function causes increased excretion of these very small proteins (54, 56-58, 72, 76, 81-89 
Tubular Proteinuria
In 1950, Friberg (81) showed increased amounts of lOwMr proteins in the urine of workers exposed to cadmium dust for long periods. Butler and Flynn (82) 
Milk and Colostrum
Human colostrum and milk contain proteins that serve two major functions for the newborn. The caseins, a-lactalbumin, several enzymes, and carrier proteins provide necessary nutrients, while immunoglobulins, lactoferrin, and lysozyme contribute to the infant's awakening immune-defense system (129) (130) (131) (132) (133) (134) (135) .
Protein content is highest in colostrum (15-68 g/L) and decreases progressively with transitional milk (13-19 g/L) and mature milk (7-11 g/L) (129, 136) . In addition to many proteins of plasma origin, human milk contains high concentrations of the various milk-specific proteins, thus making for significant differences between the electrophoretic patterns of milk and serum (137-139) .
The casein fraction of human milk consists of a complex mixture of several polymorphic proteins whose major role is to provide nutrition (140, 141) . The major whey protein, a-lactalbumin, is an important source of essential amino acids and also participates in lactose biosynthesis (142) 
